Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Denmark.
Division of Cancer Epidemiology and Genetics, NIH, Rockville, MD, USA.
J Hepatol. 2021 May;74(5):1132-1144. doi: 10.1016/j.jhep.2020.11.033. Epub 2020 Dec 1.
BACKGROUND & AIMS: Gallbladder cancer (GBC) is the most common type of biliary tract cancer, but the molecular mechanisms involved in gallbladder carcinogenesis remain poorly understood. In this study, we applied integrative genomics approaches to characterise GBC and explore molecular subtypes associated with patient survival.
We profiled the mutational landscape of GBC tumours (whole-exome sequencing on 92, targeted sequencing on 98, in total 190 patients). In a subset (n = 45), we interrogated the matched transcriptomes, DNA methylomes, and somatic copy number alterations. We explored molecular subtypes identified through clustering tumours by genes whose expression was associated with survival in 47 tumours and validated subtypes on 34 publicly available GBC cases.
Exome analysis revealed TP53 was the most mutated gene. The overall mutation rate was low (median 0.82 Mut/Mb). APOBEC-mediated mutational signatures were more common in tumours with higher mutational burden. Aflatoxin-related signatures tended to be highly clonal (present in ≥50% of cancer cells). Transcriptome-wide survival association analysis revealed a 95-gene signature that stratified all GBC patients into 3 subtypes that suggested an association with overall survival post-resection. The 2 poor-survival subtypes were associated with adverse clinicopathologic features (advanced stage, pN1, pM1), immunosuppressive micro-environments (myeloid-derived suppressor cell accumulation, extensive desmoplasia, hypoxia) and T cell dysfunction, whereas the good-survival subtype showed the opposite features.
These data suggest that the tumour micro-environment and immune profiles could play an important role in gallbladder carcinogenesis and should be evaluated in future clinical studies, along with mutational profiles.
Gallbladder cancer is highly fatal, and its causes are poorly understood. We evaluated gallbladder tumours to see if there were differences between tumours in genetic information such as DNA and RNA. We found evidence of aflatoxin exposure in these tumours, and immune cells surrounding the tumours were associated with survival.
胆囊癌(GBC)是最常见的胆道癌类型,但胆囊癌发生的分子机制仍知之甚少。在本研究中,我们应用整合基因组学方法来描述 GBC 并探索与患者生存相关的分子亚型。
我们对 GBC 肿瘤的突变景观进行了分析(92 例进行全外显子组测序,98 例进行靶向测序,共 190 例患者)。在一个亚组(n=45)中,我们检测了匹配的转录组、DNA 甲基组和体细胞拷贝数改变。我们通过聚类分析 47 例肿瘤中与生存相关的基因表达来探索分子亚型,并在 34 例公开的 GBC 病例中验证了这些亚型。
外显子组分析显示 TP53 是突变最多的基因。总的突变率较低(中位数 0.82 Mut/Mb)。APOBEC 介导的突变特征在突变负荷较高的肿瘤中更为常见。黄曲霉毒素相关特征往往是高度克隆的(存在于≥50%的癌细胞中)。全转录组生存关联分析显示,95 个基因的特征可将所有 GBC 患者分为 3 种亚型,提示与术后总生存有关。2 种不良生存亚型与不良临床病理特征(晚期、pN1、pM1)、免疫抑制微环境(髓系来源抑制细胞积累、广泛纤维变性、缺氧)和 T 细胞功能障碍相关,而良好生存亚型则表现出相反的特征。
这些数据表明,肿瘤微环境和免疫谱可能在胆囊癌的发生中发挥重要作用,应该与突变谱一起在未来的临床研究中进行评估。
胆囊癌的死亡率很高,其病因尚不清楚。我们评估了胆囊肿瘤,以观察肿瘤的 DNA 和 RNA 等遗传信息是否存在差异。我们在这些肿瘤中发现了黄曲霉毒素暴露的证据,并且肿瘤周围的免疫细胞与生存相关。